Responsible Radionuclide Cancer Care
| Autor: | J. Harvey Turner |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
Pharmacology
Cancer Research medicine.medical_specialty Radiotherapy business.industry Cancer General Medicine Medical Oncology medicine.disease Oncology Radiomics Artificial Intelligence Multidisciplinary approach Neoplasms medicine Humans Tumor board Radiologic Health Radiology Nuclear Medicine and imaging Medical physics sense organs Precision Medicine Radionuclide Imaging skin and connective tissue diseases business |
| Zdroj: | Cancer Biotherapy and Radiopharmaceuticals. 36:617-623 |
| ISSN: | 1557-8852 1084-9785 |
| DOI: | 10.1089/cbr.2021.0152 |
| Popis: | The landscape of nuclear oncology is rapidly changing. The advent of molecular radionuclide theranostics, multidisciplinary tumor board decision making, artificial intelligence and radiomics interpretation of diagnostic imaging, evolution of pharmacogenomics prediction of tumor response, and regulatory requirements for prospective individual dosimetry are just some of the elements which are broadening the essence of physician responsibility. The burgeoning knowledge base essential for mastering the emergent technologies, and their profound effect on moral philosophic aspects of provision of cancer care, are challenging. The new relationship of the theranostic nuclear physician with respect to shared care of the individual patient, particularly with regard to transparency, accountability, and responsibility for targeted radionuclide diagnosis and therapy of cancer, will be explored in this update. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|